Stay updated on ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial
Sign up to get notified when there's something new on the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page.

Latest updates to the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page
- CheckyesterdayChange DetectedVersion tag updated to v3.0.2 and the Back to Top element removed. This is a minor update with no substantive changes to core content, pricing, or availability.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has undergone significant updates, including the addition of new drug information for Danicopan and Remdesivir, as well as a focus on Post-COVID Conditions and drug safety. However, specific location details and some drug categories have been removed.SummaryDifference2%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check44 days agoChange DetectedThe page has been updated to reflect a new version, v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference0.4%
Stay in the know with updates to ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIV-5/BET-C Trial: COVID-19 Treatment Clinical Trial page.